C. H. Polman

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, C. H. Polman, Mark S. Freedman et al. · Neurology · 2006 · 677 citations

Life Sciences, Neurology, Pharmacotherapy +12

POSTWITHDRAWAL REBOUND INCREASE IN T2 LESIONAL ACTIVITY IN NATALIZUMAB-TREATED MS PATIENTS

M.M. Vellinga, Jonas A. Castelijns, Frederik Barkhof et al. · Neurology · 2007 · 146 citations

Life Sciences, Neurology, Pharmacotherapy +14

Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis

M.A.A. van Walderveen, M. W. Tas, Frederik Barkhof et al. · Neurology · 1994 · 122 citations

Medicine, Neurology, Obstetrics +14

Serum homocysteine levels in relation to clinical progression in multiple sclerosis

Charlotte E. Teunissen, Joep Killestein, Jolijn J Kragt et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 60 citations

Life Sciences, Neurology, Neuroscience +16

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

LVAE Bosma, JJ Kragt, Luís Brieva et al. · Multiple Sclerosis Journal · 2010 · 53 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +16